Pre-Conference Workshop Day
Tuesday 25th February 2025
8:30am Registration & Morning Coffee
9:00am Workshop A
Advancing Tech Transfer for Hybrid Modalities to Meet Deadlines & Deliver Drugs Faster
Synopsis
Pinpointing continuous failures and troubleshooting can be time consuming and result in downtime. This workshop will ensure you are equipped with the technical knowledge to perfect your small-scale operations and futureproof scale-up to shorten time to market. Delve into tech transfer case-studies for small molecule and small-scale advancements for large biologics to understand how to maintain end-to-end product consistency:
- Advancing your process understanding to help facilitate tech transfer
- Discussing analytical advancements and techniques to better understand early-stage analytics
- Understanding opportunities for digitalization to better understand your processes
Breakout Session
Join your peers’ post-presentations to discuss over a series of questions applicable to your area of specialty
No day selected
No day selected
11:00am Morning Refreshment Break
11:30am Workshop B
Training to Think in Continuous: Adopting Continuous Manufacturing Cross-Learnings Between Modalities to Translate Across the Complete Pipeline
Synopsis
- Developing an internal mindset to embrace continuous processing to enhance cost-efficient production along the pipeline
- Considering best internal practices to reprioritize continuous manufacturing and build a strong business case for efficient manufacturing alternatives
- Understanding small molecule applications to be applied to biologics manufacturing to move the needle forward for development
Breakout Session
Join your peers’ post-presentations to discuss over a series of questions applicable to your area of specialty
Small Molecule
Synopsis
- What are the technological capabilities required to advance continuous-informed small molecule production?
- What are some methods of proactive risk management to stabilize the shift to continuous?
- How to accelerate adoption for all small molecule therapeutics?
Large Biologics
Synopsis
- What are the technological capabilities required to advance continuous-informed biologics production?
- What are some methods of proactive risk management to communicate internally?
- How to accelerate adoption for more biologic therapeutics?